Pineridge Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.13K | Buy |
253
+1
| +0.4% | +$36 | ﹤0.01% | 231 |
|
|
2025
Q1 | $7.84K | Buy |
252
+2
| +0.8% | +$62 | ﹤0.01% | 261 |
|
|
2024
Q4 | $6.38K | Buy |
250
+78
| +45% | +$1.99K | ﹤0.01% | 357 |
|
|
2024
Q3 | $4.86K | Buy |
172
+2
| +1% | +$56 | ﹤0.01% | 348 |
|
|
2024
Q2 | $4.49K | Buy |
+170
| New | +$4.49K | ﹤0.01% | 380 |
|